Cynthia Egan, Director at BlackRock Health Sciences Trust II (BMEZ), bought 3,974 shares at $29.30 ($116K) on 2020-12-21, disclosed to the SEC on 2020-12-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.30 | 1,987 | $58K | 50.0% |
| 2 | $29.30 | 1,987 | $58K | 50.0% |
| Total | $29.30 avg | 3,974 | $116K | 100% |
| Filing → |
| BSTZ | BUY | 2020-12-23 | $117K | — | Filing → |
| BGY | BUY | 2020-12-23 | $58K | — | Filing → |
| BME | BUY | 2019-07-02 | $291K | — | Filing → |